Number of the records: 1
Sacubitril/Valsartan and Ivabradine Attenuate Left Ventricular Remodelling and Dysfunction in Spontaneously Hypertensive Rats: Different Interactions with the Renin-Angiotensin-Aldosterone System
Title Sacubitril/Valsartan and Ivabradine Attenuate Left Ventricular Remodelling and Dysfunction in Spontaneously Hypertensive Rats: Different Interactions with the Renin-Angiotensin-Aldosterone System Author Šimko Fedor SAVBIOMED ; SAVEXEND - Biomedicínske centrum SAV ORCID Co-authors Baka T. Stanko Peter Repova Bednarova Kristina Krajčirovičová Kristína Aziriová S. Domenig O. Zorad Štefan SAVBIOMED ; SAVEXEND - Biomedicínske centrum SAV SCOPUS RID ORCID Adamcová Michaela Paulis Ľudovít 1981- SAVNOPAT - Ústav normálnej a patologickej fyziológie SAV SCOPUS ORCID Source document Biomedicines. Vol. 10, no. 8 (2022), art. no. 1844 Language eng - English Country CH - Switzerland Document kind rozpis článkov z periodík (rbx) Citations KAMISAH, Y. - HASSAN, H.H.C. Therapeutic Use and Molecular Aspects of Ivabradine in Cardiac Remodeling: A Review. In INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. FEB 2023, vol. 24, no. 3. JEREMIC, J. - GOVORUSKINA, N. - BRADIC, J. - MILOSAVLJEVIC, I. - SREJOVIC, I. - ZIVKOVIC, V. - JEREMIC, N. - TURNIC, T.N. - TANASKOVIC, I. - BOLEVICH, S. - JAKOVLJEVIC, V. - BOLEVICH, S. - ZIVANOVIC, M.N. - OKWOSE, N. - SEKLIC, D. - MILIVOJEVIC, N. - GRUJIC, J. - VELICKI, L. - MACGOWAN, G. - JAKOVLJEVIC, D.G. - FILIPOVIC, N. Sacubitril/valsartan reverses cardiac structure and function in experimental model of hypertension-induced hypertrophic cardiomyopathy. In MOLECULAR AND CELLULAR BIOCHEMISTRY. ISSN 0300-8177, 2023 MAR 30 2023. Category ADCA - Scientific papers in foreign journals registered in Current Contents Connect with IF (impacted) Category of document (from 2022) V3 - Vedecký výstup publikačnej činnosti z časopisu Type of document článok Year 2022 Registered in WOS Registered in SCOPUS Registered in CCC DOI 10.3390/biomedicines10081844 
article
rok CC IF IF Q (best) JCR Av Jour IF Perc SJR SJR Q (best) CiteScore A rok vydania rok metriky IF IF Q (best) SJR SJR Q (best) 2022 2021 4.757 Q2 0.874 Q1
Number of the records: 1